chr6-152239609-G-A
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_182961.4(SYNE1):c.19991C>T(p.Thr6664Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000617 in 1,614,198 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.19991C>T | p.Thr6664Ile | missense_variant | 108/146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.19991C>T | p.Thr6664Ile | missense_variant | 108/146 | 1 | NM_182961.4 | ENSP00000356224 | P1 | |
SYNE1 | ENST00000423061.6 | c.19778C>T | p.Thr6593Ile | missense_variant | 107/146 | 1 | ENSP00000396024 | |||
SYNE1 | ENST00000367256.9 | n.3683C>T | non_coding_transcript_exon_variant | 23/61 | 1 | |||||
SYNE1 | ENST00000409694.6 | n.3575C>T | non_coding_transcript_exon_variant | 21/59 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00309 AC: 470AN: 152192Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000871 AC: 219AN: 251388Hom.: 0 AF XY: 0.000729 AC XY: 99AN XY: 135860
GnomAD4 exome AF: 0.000356 AC: 520AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.000345 AC XY: 251AN XY: 727244
GnomAD4 genome AF: 0.00313 AC: 476AN: 152310Hom.: 1 Cov.: 33 AF XY: 0.00305 AC XY: 227AN XY: 74468
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 16, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 20, 2018 | - - |
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at